.pdf&w=65&h=83&zc=1&q=90)
Bump Stock Ban, the Abortion Pill and Social Media Regulation on the Docket
Garland v. Cargill, FDA v. Alliance for Hippocratic Medicine, Moody v. NetChoice and Others
Below is the status of key cases granted certiorari by the U.S. Supreme Court for consideration during the October 2023 (Oct. 2, 2023, to Oct. 6, 2024) and October 2024 (Oct. 7, 2024, to Oct. 5, 2025) terms, as of April 29, 2024. Cases are organized by certiorari date within each section. Abortion Food and Drug Administration (FDA) v. Alliance for Hippocratic Medicine — This case was granted certiorari on Dec. 13, 2023, and was argued on March 26, 2024. At issue is whether the FDA approval of and subsequent rulemaking for the abortion drug mifepristone was “arbitrary and…
